
Uneven Skin Tone and Texture
Dyschromia and Keratinisation Disorders
Authored by
Pavesan Naidoo Msc (c) pharmaceutical science B.Pharm
Published 1st May 2025
What is uneven skin tone and texture
Many of us experience skin that isn't perfectly smooth or consistently colored. These common concerns, where your skin tone and texture appear uneven, can stem from a variety of factors. In the world of skincare, these issues often fall under the term "dyschromia," which simply refers to irregularities in skin color. This includes darker patches (hyperpigmentation), like those that can appear after a breakout or from sun exposure (such as post-inflammatory hyperpigmentation and melasma), as well as lighter patches (hypopigmentation).
Beyond color, the feel of our skin can also be uneven. Conditions affecting the skin's surface, known as disorders of keratinization, can lead to bumps, roughness, or scaling. Common examples include keratosis pilaris (those tiny bumps often found on the upper arms and thighs) and xerotic scaling (dry, flaky skin).
While these skin changes are usually harmless, they can definitely affect how our skin looks and feels, and for many, this can impact their confidence. This is particularly true for individuals with darker skin tones, who may find their skin is more prone to changes in pigmentation after inflammation or injury.
Understanding uneven skin tone and texture
Dyschromia: When Skin Pigmentation Goes Awry
Our skin's color is primarily determined by melanin, a complex pigment synthesized by specialized cells called melanocytes located in the basal layer, the deepest layer of the epidermis. The production of melanin, a process termed melanogenesis, involves a cascade of enzymatic reactions, with tyrosinase serving as the rate-limiting enzyme and a key biochemical target in managing hyperpigmentation. Various factors can influence melanocyte activity, including exposure to ultraviolet radiation (UVR), the energy from sunlight that can stimulate pigment production, hormonal fluctuations, and inflammatory signals.
Hyperpigmentation, characterized by an excess (hyper) of melanin, can manifest in several forms. Post-inflammatory hyperpigmentation (PIH) is a common sequela, or consequence, of cutaneous inflammation resulting from conditions like acne vulgaris or eczema. The inflammatory cascade triggers the release of cytokines, small signaling proteins that communicate between cells, and other signaling molecules that stimulate melanocytes to increase melanin synthesis. The depth of melanin deposition dictates the clinical presentation of PIH: epidermal melanin, located within the basal keratinocytes, the main skin cells in the deepest layer of the epidermis, typically appears brown and is generally more amenable to topical treatment. In contrast, dermal melanin, residing within melanophages, which are immune cells that engulf (phage) melanin in the dermis (the layer beneath the epidermis), often presents as a blue-gray hue and is more challenging to address due to its deeper location.
Keratinization Disorders: Disruptions in Skin Cell Development and Shedding
The smooth texture of healthy skin relies on the orderly maturation of keratinocytes, the primary cells of the epidermis that produce keratin, as they migrate from the basal layer to the stratum corneum, the outermost epidermal layer. This process of keratinization culminates in the formation of tightly packed, dead cells called corneocytes that form the skin's protective barrier. The continuous shedding of these corneocytes, known as desquamation, is essential for maintaining a smooth skin surface. This shedding is facilitated by the enzymatic breakdown of corneodesmosomes, protein structures that act like "glue" adhering (desmo) the corneocytes together, by enzymes like kallikrein-related peptidases (KLKs).
Conditions like keratosis pilaris (KP) exemplify disorders of keratinization. KP is characterized by follicular hyperkeratosis, an excessive (hyper) buildup of keratin within the hair follicles (follicular), leading to the characteristic rough, bumpy texture. While the exact cause is not fully understood, a deficiency in filaggrin, a structural protein crucial for epidermal barrier function and the formation of the natural moisturizing factor (NMF), has been implicated. The NMF comprises hygroscopic molecules that attract (hygro) and retain water within the stratum corneum, contributing to its hydration and flexibility. Filaggrin deficiency is thought to disrupt normal corneocyte cohesion and the desquamation process, resulting in keratin retention.
The Interplay of Hydration and Barrier Function:
The water content of the stratum corneum, referred to as stratum corneum hydration, is critical for maintaining both skin texture and barrier function. When stratum corneum hydration is suboptimal, a state known as xerosis, the skin becomes abnormally dry. This compromised barrier function can also indirectly influence pigmentation. A disrupted stratum corneum may allow increased penetration of irritants, triggering inflammatory responses that can stimulate melanogenesis, potentially exacerbating or contributing to hyperpigmentation in susceptible individuals. Factors that contribute to xerosis, such as low ambient humidity and the use of harsh surfactants, which are ingredients in cleansers that can strip the skin of its natural oils, can thus have downstream effects on both skin texture and tone. Maintaining adequate hydration and a healthy epidermal barrier are therefore crucial for overall skin health and a more even, smoother complexion.
A technical analysis
Dyschromia: Aberrations in Cutaneous Pigmentation The intricate process of melanogenesis, orchestrated within melanocytes residing in the basal layer of the epidermis, is central to the development of hyperpigmentation. This process involves the enzymatic conversion of L-tyrosine to melanin through a series of oxidation reactions catalyzed by tyrosinase, a key target for numerous depigmenting agents. The rate and type of melanin synthesized (eumelanin, a brown-black pigment, or pheomelanin, a red-yellow pigment) are influenced by genetic factors, hormonal milieu, and environmental cues, notably ultraviolet radiation (UVR).  Hyperpigmentation, characterized by an increased melanin content in the skin, can manifest in various forms. Post-inflammatory hyperpigmentation (PIH) exemplifies a reactive melanogenesis cascade. Following cutaneous inflammation triggered by acne vulgaris, atopic dermatitis, or mechanical trauma, the release of pro-inflammatory cytokines, including tumor necrosis factor-alpha (TNF-α), interleukin-1 alpha (IL-1α), and prostaglandins, directly stimulates melanocytes to increase melanin synthesis. Furthermore, keratinocytes activated by inflammatory stimuli release melanocyte-stimulating hormone (α-MSH) and stem cell factor (SCF), which bind to melanocortin 1 receptor (MC1R) and c-KIT receptor on melanocytes, respectively, further promoting melanogenesis. The clinical presentation and persistence of PIH are largely determined by the depth of melanin deposition. Epidermal hyperpigmentation, where melanin is primarily located within basal keratinocytes, typically presents as light to dark brown macules and is generally more responsive to topical therapies targeting epidermal melanocytes and melanin transfer. In contrast, dermal hyperpigmentation, characterized by melanin accumulation within dermal macrophages (melanophages), often appears as blue-gray or slate-colored patches and is more recalcitrant to treatment due to the pigment's deeper location and relative inaccessibility to topical agents.  Melasma, another common hyperpigmentary disorder, is characterized by symmetrical hyperpigmented patches predominantly on sun-exposed areas of the face. Its pathogenesis is complex and multifactorial, involving hormonal influences (e.g., estrogen, progesterone), UVR exposure, genetic predisposition, and increased melanocyte sensitivity. While the precise molecular mechanisms are still under investigation, studies suggest an upregulation of melanogenic enzymes, increased melanocyte proliferation, and enhanced transfer of melanosomes to keratinocytes. Furthermore, alterations in the dermal microenvironment, including increased vascularization and mast cell activation, are implicated in melasma development and maintenance.  Keratinization Disorders: Aberrant Epidermal Differentiation and Desquamation Uneven skin texture frequently arises from disruptions in the tightly regulated processes of keratinocyte differentiation and desquamation within the epidermis. Normal epidermal homeostasis involves the orderly maturation of keratinocytes from the basal layer to the stratum corneum, accompanied by the synthesis of keratin filaments and the formation of the cornified envelope. Desquamation, the shedding of terminally differentiated corneocytes, is a crucial process for maintaining a smooth skin surface and a functional epidermal barrier. This process is mediated by the enzymatic degradation of corneodesmosomes, adhesive structures between corneocytes, by serine proteases, including kallikrein-related peptidases (KLKs), whose activity is tightly controlled by serine protease inhibitors (serpins).  Keratosis pilaris (KP) exemplifies a disorder of keratinization characterized by follicular hyperkeratosis. The hallmark of KP is the accumulation of keratin plugs within hair follicles, resulting in the characteristic rough, bumpy texture predominantly observed on the extensor surfaces of the upper arms and thighs. While the exact etiology remains elusive, genetic predisposition, particularly mutations in the filaggrin gene, has been strongly implicated. Filaggrin is a key structural protein in the granular layer of the epidermis that undergoes proteolysis to generate components of the NMF (natural moisturizing factor), crucial for stratum corneum hydration and barrier function. Filaggrin deficiency is thought to disrupt corneocyte cohesion and impair the normal desquamation process, leading to keratin retention within the follicular infundibulum. Interestingly, despite the abnormal keratinization, studies have often reported unchanged overall lipid composition in the stratum corneum of individuals with KP, suggesting a primary defect in keratinocyte differentiation and desquamation rather than lipid synthesis. The resulting follicular hyperkeratosis contributes to a compromised epidermal barrier, potentially increasing transepidermal water loss (TEWL) and exacerbating skin roughness.  The Interplay of Hydration and Barrier Function in Skin Texture and Tone Xerosis, or clinical skin dryness resulting from diminished stratum corneum hydration, significantly contributes to uneven skin texture and can indirectly influence skin tone. When the water content of the stratum corneum falls below critical thresholds, the structural integrity of this outermost layer is compromised. Reduced hydration impairs corneocyte flexibility and promotes increased corneocyte cohesion in some contexts, leading to the formation of visible scales and microfissures on the skin surface. This disruption of the smooth epidermal architecture directly contributes to tactile roughness and an overall uneven skin texture. Furthermore, barrier dysfunction associated with xerosis can trigger a cascade of events that indirectly impact melanogenesis. A compromised stratum corneum allows for increased penetration of irritants and potential inflammatory stimuli. These stimuli can activate keratinocytes to release pro-inflammatory cytokines and melanogenic mediators, potentially leading to the development or exacerbation of hyperpigmentation, particularly in individuals predisposed to PIH. Factors commonly contributing to xerosis, such as low environmental humidity, the use of harsh surfactants that strip the skin of its natural lipids, and inadequate or improper exfoliation practices that disrupt the normal desquamation process, can thus create a microenvironment conducive to both textural irregularities and pigmentary disturbances. The maintenance of adequate stratum corneum hydration and a functional epidermal barrier is therefore crucial not only for achieving a smooth skin texture but also for preventing the development or worsening of uneven skin tone.
Treatment strategy
Dealing with dry skin effectively often involves understanding how different creams and treatments work to restore your skin's natural balance. Think of your skin's outermost layer as a protective wall; when it's healthy, it keeps moisture in and external irritants out. This wall relies on essential fats and natural moisturizing factors within the skin cells. When skin becomes dry, it's often because this barrier is compromised and these natural moisturizers are depleted.
Fortunately, our skincare products are specifically designed to address these underlying issues. One key strategy involves products designed to replenish the skin's natural fats, much like repairing the "mortar" in a wall. Ingredients such as ceramides and cholesterol, which are naturally found in your skin, help to rebuild this protective layer, making it more effective at retaining moisture.
Another important approach involves products designed to boost the skin's natural ability to hold water. Certain ingredients, like urea, glycerin, and PCA, act as humectants, essentially attracting and binding water to the skin cells, much like tiny sponges. This helps to rehydrate the skin and improve its overall feel.
Sometimes, dry skin can appear flaky due to a buildup of dead skin cells that aren't shedding properly. Products designed to gently exfoliate help to address this, encouraging the natural turnover of skin cells and revealing smoother, more hydrated skin underneath.
Furthermore, dry skin can sometimes be accompanied by irritation. In these cases, treatments designed to include calming and anti-inflammatory ingredients can be beneficial, helping to soothe the skin and support the recovery of a healthy barrier function.
A technical analysis
A cornerstone of xerosis management involves lipid barrier replenishment. Given the critical role of ceramides, cholesterol, and free fatty acids in maintaining the structural integrity and impermeability of the stratum corneum, topical application of formulations containing these key lipids is paramount. Examples of active ingredients employed for this purpose include Ceramide NP, phytosphingosine (a ceramide precursor), and squalane, a lipid emollient that mimics the skin's natural sebum. By directly supplying these essential lipids, the aim is to repair the disrupted lamellar structure, thereby reducing transepidermal water loss (TEWL) and improving barrier function. Another crucial therapeutic target is natural moisturizing factor (NMF) restoration. The NMF, a complex mixture of hygroscopic substances within corneocytes, plays a vital role in attracting and binding water, maintaining skin hydration and flexibility. Interventions aimed at boosting humectants and the skin's overall water-binding capacity often incorporate ingredients such as urea (typically at concentrations of 5-10%), glycerin, pyrrolidone carboxylic acid (PCA), and lactate. These molecules act as water magnets, drawing moisture from the environment and the deeper layers of the skin into the stratum corneum, thereby alleviating dryness. Dysregulation of desquamation, the natural shedding of corneocytes, can contribute to the accumulation of dry, scaly skin in xerosis. Therefore, strategies to modulate protease activity and enhance exfoliation represent another avenue for intervention. Certain active ingredients, such as lactobionic acid and gluconolactone (polyhydroxy acids or PHAs), offer gentle exfoliation by influencing the bonds between corneocytes. These agents can help to remove the buildup of dry, superficial skin cells, revealing smoother, more hydrated layers beneath. In cases where underlying inflammation exacerbates barrier disruption in xerosis, anti-inflammatory interventions can be beneficial. Active ingredients like niacinamide (a form of vitamin B3), panthenol (pro-vitamin B5), and bisabolol (a component of chamomile) possess soothing and anti-inflammatory properties. By calming cytokine-mediated pathways that can impair barrier function, these agents can help to reduce redness, irritation, and further compromise of the skin's protective mechanisms. Finally, occlusion, the formation of a physical barrier on the skin surface to prevent water loss, remains a fundamental principle in xerosis management. Film-forming agents create a hydrophobic layer that reduces TEWL, allowing the underlying skin to rehydrate. Common occlusive ingredients include petrolatum, dimethicone (a silicone-based polymer), and shea butter. These substances effectively seal the skin's surface, minimizing evaporation and enhancing the efficacy of other moisturizing agents.
Shop our treatment package
Learn more about our treatment package
01
Hyaluronic acid serum
04
Gentle cleanser
02
All day nourishing body cream
03
Lamellar Facial Moisturizer